Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (150) 150
life sciences & biomedicine (149) 149
humans (132) 132
abridged index medicus (92) 92
general & internal medicine (75) 75
medicine, general & internal (75) 75
internal medicine (68) 68
history, 20th century (56) 56
hematology (52) 52
oncology (48) 48
male (44) 44
philately (40) 40
female (37) 37
aged (31) 31
middle aged (30) 30
biological and medical sciences (29) 29
myelodysplastic syndromes (28) 28
medical sciences (27) 27
history, 19th century (25) 25
adult (22) 22
prognosis (22) 22
stamp vignette on medical science (22) 22
hematologic and hematopoietic diseases (21) 21
nobel prize (21) 21
united states (20) 20
aged, 80 and over (18) 18
cancer (18) 18
hematology, oncology and palliative medicine (17) 17
myelodysplastic syndromes - drug therapy (17) 17
treatment outcome (16) 16
leukemia (15) 15
myelodysplastic syndrome (15) 15
care and treatment (14) 14
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (13) 13
mutation (13) 13
myelodysplastic syndromes - mortality (13) 13
myelodysplastic syndromes - therapy (13) 13
research (13) 13
risk factors (13) 13
anemia (12) 12
myelodysplastic syndromes - diagnosis (12) 12
retrospective studies (12) 12
health aspects (10) 10
history, 21st century (10) 10
myelodysplastic syndromes - genetics (10) 10
myelodysplastic syndromes - pathology (10) 10
stem cells (10) 10
azacitidine - analogs & derivatives (9) 9
bone marrow - pathology (9) 9
diagnosis, differential (9) 9
mortality (9) 9
acute myeloid leukemia (8) 8
antineoplastic agents - therapeutic use (8) 8
decitabine (8) 8
survival rate (8) 8
transplantation (8) 8
tumors (8) 8
animals (7) 7
bone marrow (7) 7
chemotherapy (7) 7
clinical trials (7) 7
physicians (7) 7
studies (7) 7
azacitidine (6) 6
azacitidine - therapeutic use (6) 6
disease-free survival (6) 6
erythrocyte transfusion (6) 6
general aspects (6) 6
germany (6) 6
hematopoietic stem cell transplantation (6) 6
patients (6) 6
physicians - history (6) 6
risk (6) 6
survival analysis (6) 6
analysis (5) 5
antimetabolites, antineoplastic - therapeutic use (5) 5
biopsy (5) 5
chromosome aberrations (5) 5
drug therapy, combination (5) 5
england (5) 5
genetic aspects (5) 5
hematinics - therapeutic use (5) 5
hematopoietic stem cells (5) 5
history, 18th century (5) 5
hospitals (5) 5
mds (5) 5
medical research (5) 5
medicine (5) 5
myelodysplastic syndromes - classification (5) 5
myelodysplastic syndromes - metabolism (5) 5
pathology (5) 5
philately - history (5) 5
quality of life (5) 5
acute disease (4) 4
age (4) 4
age factors (4) 4
anemia - etiology (4) 4
anemias. hemoglobinopathies (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
by Bohlius, Julia, MD and Schmidlin, Kurt, DMD and Brillant, Corinne, MSc and Schwarzer, Guido, PhD and Trelle, Sven, MD and Seidenfeld, Jerome, PhD and Zwahlen, Marcel, PhD and Clarke, Michael, Prof and Weingart, Olaf, MD and Kluge, Sabine, MA and Piper, Margaret, PhD and Rades, Dirk, MD and Steensma, David P, MD and Djulbegovic, Benjamin, Prof and Fey, Martin F, Prof and Ray-Coquard, Isabelle, MD and Machtay, Mitchell, Prof and Moebus, Volker, Prof and Thomas, Gillian, Prof and Untch, Michael, Prof and Schumacher, Martin, Prof and Egger, Matthias, Prof and Engert, Andreas, Prof
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1532 - 1542
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Young Adult | Neoplasms - complications | Anemia - drug therapy | Adult | Female | Anemia - etiology | Effect Modifier, Epidemiologic | Hematinics - therapeutic use | Erythrocyte Transfusion | Proportional Hazards Models | Neoplasms - mortality | Hematinics - adverse effects | Linear Models | Survival Rate | Treatment Outcome | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Adolescent | Aged | Research Design | Prevention | Complications and side effects | Care and treatment | Anemia | Research | Comparative analysis | Blood transfusion | Health aspects | Risk factors | Erythropoietin, Recombinant | Cancer | Studies | Clinical trials | Radiation therapy | Mortality | Meta-analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
by Garcia-Manero, Guillermo, Dr Prof and Fenaux, Pierre, Prof and Al-Kali, Aref, MD and Baer, Maria R, Prof and Sekeres, Mikkael A, Prof and Roboz, Gail J, Prof and Gaidano, Gianluca, Prof and Scott, Bart L, MD and Greenberg, Peter, Prof and Platzbecker, Uwe, Prof and Steensma, David P, MD and Kambhampati, Suman, MD and Kreuzer, Karl-Anton, Prof and Godley, Lucy A, Prof and Atallah, Ehab, MD and Collins, Robert, Prof and Kantarjian, Hagop, Prof and Jabbour, Elias, MD and Wilhelm, Francois E, MD and Azarnia, Nozar, PhD and Silverman, Lewis R, MD and ONTIME study investigators and ONTIME Study Investigators
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 496 - 508
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Glycine - analogs & derivatives | Azacitidine - adverse effects | Drug Administration Schedule | Glycine - adverse effects | Europe | Humans | Middle Aged | Kaplan-Meier Estimate | Sulfones - adverse effects | Azacitidine - analogs & derivatives | Male | Risk | Treatment Outcome | Disease-Free Survival | Female | Aged | Myelodysplastic Syndromes - pathology | DNA Methylation - drug effects | Glycine - administration & dosage | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | Sulfones - administration & dosage | Drugs | Care and treatment | Leukemia | Oncology, Experimental | Product development | Research | Patients | Drug approval | Myelodysplastic syndromes | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
by Li, Weijuan and Croce, Kevin and Steensma, David P and McDermott, David F and Ben-Yehuda, Ori and Moslehi, Javid
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2015, Volume 66, Issue 10, pp. 1160 - 1178
vascular toxicity | cardiotoxicity | cardio-oncology | metabolic toxicity | Hyperglycemia | Kinases | Drug therapy | Cancer therapies | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Independent Validation of the MD Anderson Cancer Center Risk Model for Myelodysplastic Syndromes (MDS), and Comparison to the International Prognostic Scoring System (IPSS) and the World Health Organization-Based Prognostic Scoring System (WPSS)
by Hugo, Sarah E and Bundrick, Sarah C and Hanson, Curtis A and Steensma, David P
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 3814 - 3814
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in AML Patients Who Achieve a Chemotherapy-Induced Remission
by Rosenblatt, Jacalyn, MD and Stone, Richard M., MD and Uhl, Lynne, MD and Neuberg, Donna, ScD and Vasir, Baldev, PhD and Somaiya, Poorvi and Joyce, Robin, MD and Levine, James D., MD and Boussiotis, Vassiliki A., MD, PhD and Zwicker, Jeffrey, MD and Arnason, Jon E., MD and Luptakova, Katarina, MD and Steensma, David P., MD and DeAngelo, Daniel J., MD and Galinsky, Ilene, ANP and Delaney, Carol, RN and Mills, Heidi, BA and Breault, Emma and Stroopinsky, Dina, PhD and Kufe, Donald, MD and Avigan, David, MD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 2, pp. S50 - S50
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Biomedical System Dynamics to Improve Anemia Control With Darbepoetin Alfa in Long-Term Hemodialysis Patients
by McCarthy, James T., MD and Hocum, Craig L., PA-C and Albright, Robert C., DO and Rogers, James, MS, MBA and Gallaher, Edward J., PhD and Steensma, David P., MD and Gudgell, Stephen F., MA and Bergstralh, Eric. J., MS and Dillon, John C., MD and Hickson, LaTonya J., MD and Williams, Amy W., MD and Dingli, David, MD, PhD
Mayo Clinic proceedings, ISSN 0025-6196, 2014, Volume 89, Issue 1, pp. 87 - 94
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prospective Studies | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Humans | Middle Aged | Erythropoiesis - drug effects | Male | Dose-Response Relationship, Drug | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Renal Dialysis - adverse effects | Aged, 80 and over | Female | Aged | Retrospective Studies | Darbepoetin alfa | Patient Care Management - organization & administration | Anemia - etiology | Hemoglobins - analysis | Dosage and administration | Drug therapy | Anemia | Hemodialysis patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis
by El-Jawahri, Areej, Dr and Keenan, Tanya, MD and Abel, Gregory A, MD and Steensma, David P, MD and LeBlanc, Thomas W, MD and Chen, Yi-Bin, MD and Hobbs, Gabriela, MD and Traeger, Lara, PhD and Fathi, Amir T, MD and DeAngelo, Daniel J, MD and Wadleigh, Martha, MD and Ballen, Karen K, Prof and Amrein, Philip C, MD and Stone, Richard M, Prof and Temel, Jennifer S, MD
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 6, pp. e276 - e283
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Follow-Up Studies | United States | Humans | Hospitalization - statistics & numerical data | Male | Palliative Care | Practice Patterns, Physicians | Time Factors | Female | Aged | Patient Admission - statistics & numerical data | Retrospective Studies | Odds Ratio | Leukemia, Myeloid, Acute - therapy | Needs Assessment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Antonius Mathijsen and Plaster Casts
by Afshar, Ahmadreza, MD and Steensma, David P., MD and Kyle, Robert A., MD
Mayo Clinic proceedings, ISSN 0025-6196, 2017, Volume 92, Issue 5, pp. e83 - e83
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | History, Ancient | Orthopedic Surgeons - history | Netherlands | Casts, Surgical - history | Humans | History, 19th Century | History, 18th Century | Surgeons | Medical dressings | Avicenna (980-1037) | Orthopedics | Colleges & universities | Index Medicus | Mathijsen | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The Medical Doctors of Star Trek : Leonard “Bones” McCoy and Beverly Crusher
by Steensma, David P., MD and Kyle, Robert A., MD
Mayo Clinic proceedings, ISSN 0025-6196, 2016, Volume 92, Issue 1, pp. e9 - e10
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Van Gogh’s Portrait of Dr Gachet
by Steensma, David P., MD and Kyle, Robert A., MD
Mayo Clinic proceedings, ISSN 0025-6196, 2016, Volume 92, Issue 3, pp. e57 - e58
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Hendrik van Deventer: Dutch Obstetrician and Orthopedist
by Steensma, David P., MD and Kyle, Robert A., MD
Mayo Clinic proceedings, ISSN 0025-6196, 2016, Volume 91, Issue 12, pp. e171 - e171
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | History, 17th Century | Orthopedic Surgeons - history | Netherlands | Humans | Philately | History, 18th Century | Obstetrics - history | Physicians - history | Index Medicus | Abridged Index Medicus | van Deventer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
by Steensma, David P., MD and Gattermann, Norbert, MD
Best practice & research. Clinical haematology, ISSN 1521-6926, 2013, Volume 26, Issue 4, pp. 431 - 444
Hematology, Oncology and Palliative Medicine | deferiprone | red blood cell transfusion [complications] | haemosiderosis | deferoxamine | myelodysplastic syndromes | iron | chelation therapy | deferasirox | Life Sciences & Biomedicine | Hematology | Science & Technology | Iron Chelating Agents - therapeutic use | Myelodysplastic Syndromes - metabolism | Iron Overload - mortality | Myelodysplastic Syndromes - diagnostic imaging | Iron Overload - drug therapy | Humans | Clinical Trials as Topic | Iron - metabolism | Myelodysplastic Syndromes - complications | Iron Overload - diagnostic imaging | Radiography | Magnetic Resonance Imaging | Iron Overload - complications | Iron Overload - metabolism | Myelodysplastic Syndromes - mortality | Myelodysplastic Syndromes - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Anemia in the Elderly: How Should We Define It, When Does It Matter, and What Can Be Done?
by Steensma, David P., MD and Tefferi, Ayalew, MD
Mayo Clinic proceedings, ISSN 0025-6196, 2007, Volume 82, Issue 8, pp. 958 - 966
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Anemias. Hemoglobinopathies | Biological and medical sciences | General aspects | Medical sciences | Diseases of red blood cells | Anemia - classification | Hematinics - therapeutic use | Anemia - blood | Humans | Renal Insufficiency - complications | Survival Rate | Aged | Health Status | Nutrition Disorders - complications | Myelodysplastic Syndromes - complications | Anemia - etiology | Hemoglobins - analysis | Evaluation | Aged patients | Diagnosis | Anemia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights